Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Spironolactone may help treat excessive hair growth in girls, but more research is needed.

The document does not determine if adults with aphallia are fertile.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

A girl inherited excessive body hair from her mother and grandmother.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.